FIELD: medicine.
SUBSTANCE: an intermittent transplantable tumour is formed in an experimental animal. After the transplantable tumour reached a size not less than 0.5 cm in diameter, growing new lymph nodes are observed in a regional areas from the tumour.
EFFECT: method provides neolymphogenesis modelling with increased number of the lymph nodes in 2-3 times.
2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| BIOMATERIAL AND PREPARATION WITH BIOMATERIAL, STIMULATING ANTI-TUMOUR ACTIVITY | 2013 |
|
RU2526160C1 |
| METHOD FOR STAGING CANCER IN VITRO | 2007 |
|
RU2333776C1 |
| METHOD FOR ASSESSING SURGICAL RADICALITY IN SKIN CANCER | 2011 |
|
RU2465587C1 |
| A METHOD FOR MODELING THE PRIMARY MULTIPLE GROWTH OF MALIGNANT TUMORS WITH THE SUPPRESSION OF ONE TUMOR BY ANOTHER IN THE CONDITIONS OF PRIMARY IMMUNODEFICIENCY | 2021 |
|
RU2750127C1 |
| METHOD FOR MURINE MELANOMA LYMPHATIC AND HEMATOGENOUS METASTASIS B SIMULATION FOR NONLINEAR WHITE RATS | 2016 |
|
RU2615908C1 |
| METHOD OF BREAST CANCER PATIENT REHABILITATION (VERSIONS) | 2009 |
|
RU2413526C1 |
| METHOD OF LYMPHODISSECTION IN VIVO AT CANCER | 2007 |
|
RU2340293C1 |
| METHOD FOR LOCAL PROLONGED CHEMOTHERAPY OF LOCALLY ADVANCED NONRESECTABLE DIGESTIVE ADENOCARCINOMA | 2010 |
|
RU2460530C2 |
| METHOD OF PREDICTING DISTANT RESULTS OF URINARY BLADDER CANCER TREATMENT | 2010 |
|
RU2456926C2 |
| CERVICAL CANCER NEOADJUVANT CHEMOTHERAPY METHOD | 2009 |
|
RU2405544C1 |
